Precigen Long Term Debt vs Current Deferred Revenue Analysis

PGEN Stock

USD 1.42 0.02 1.43%

Precigen financial indicator trend analysis is much more than just breaking down Precigen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Precigen is a good investment. Please check the relationship between Precigen Long Term Debt and its Current Deferred Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.

Long Term Debt vs Current Deferred Revenue

Long Term Debt vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Precigen Long Term Debt account and Current Deferred Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Precigen's Long Term Debt and Current Deferred Revenue is -0.47. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Precigen, assuming nothing else is changed. The correlation between historical values of Precigen's Long Term Debt and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Precigen are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Long Term Debt i.e., Precigen's Long Term Debt and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.47

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Long Term Debt

Long-term debt is a debt that Precigen has held for over one year. Long-term debt appears on Precigen balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Precigen balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Precigen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Precigen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.At this time, Precigen's Discontinued Operations is very stable compared to the past year. As of the 4th of May 2024, Sales General And Administrative To Revenue is likely to grow to 1.09, while Selling General Administrative is likely to drop about 38.4 M.

	2021	2022	2023	2024 (projected)
Interest Expense	18.9M	6.8M	468K	444.6K
Depreciation And Amortization	1.3M	2.5M	6.7M	9.4M

Interest Expense Depreciation And Amortization

Precigen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Good Will
Total Assets		0.06	0.33	0.65	0.9	0.67	0.9	-0.3	0.21	0.69	0.84	0.98	0.46	0.81	0.94	0.09	0.62	0.1	0.62	0.28	0.25	0.86	0.89	-0.13	0.9	0.95
Short Long Term Debt Total	0.06		0.64	0.4	-0.04	0.54	-0.23	0.91	-0.57	0.47	0.33	-0.08	-0.59	0.15	0.21	0.44	0.01	0.14	0.51	0.54	0.23	0.18	0.36	0.37	-0.1	0.13
Other Current Liab	0.33	0.64		0.83	0.28	0.52	0.13	0.5	-0.48	0.41	0.42	0.21	-0.45	0.23	0.48	0.47	0.02	-0.08	0.65	0.57	0.13	0.42	0.54	0.62	0.29	0.36
Total Current Liabilities	0.65	0.4	0.83		0.54	0.64	0.54	0.2	-0.21	0.6	0.54	0.57	-0.08	0.39	0.75	0.37	0.22	0.03	0.67	0.49	0.28	0.57	0.72	0.6	0.59	0.66
Total Stockholder Equity	0.9	-0.04	0.28	0.54		0.48	0.75	-0.34	0.0	0.54	0.7	0.86	0.31	0.84	0.83	0.32	0.73	-0.34	0.63	0.49	-0.19	0.81	0.84	-0.08	0.81	0.83
Property Plant And Equipment Net	0.67	0.54	0.52	0.64	0.48		0.52	0.29	-0.1	0.9	0.67	0.64	0.16	0.43	0.65	0.18	0.18	0.3	0.61	0.36	0.44	0.66	0.61	0.04	0.58	0.75
Current Deferred Revenue	0.9	-0.23	0.13	0.54	0.75	0.52		-0.5	0.35	0.54	0.6	0.94	0.6	0.61	0.82	-0.06	0.49	0.24	0.49	0.06	0.37	0.66	0.65	-0.25	0.92	0.86
Net Debt	-0.3	0.91	0.5	0.2	-0.34	0.29	-0.5		-0.66	0.23	-0.08	-0.42	-0.76	-0.17	-0.14	0.45	-0.19	0.05	0.3	0.46	0.1	-0.13	0.02	0.44	-0.43	-0.21
Retained Earnings	0.21	-0.57	-0.48	-0.21	0.0	-0.1	0.35	-0.66		-0.09	0.13	0.31	0.84	0.03	0.05	-0.9	0.0	0.52	-0.57	-0.86	0.45	0.19	-0.05	-0.42	0.14	0.08
Accounts Payable	0.69	0.47	0.41	0.6	0.54	0.9	0.54	0.23	-0.09		0.63	0.65	0.23	0.55	0.7	0.22	0.39	0.21	0.59	0.38	0.35	0.59	0.67	0.03	0.59	0.82
Cash	0.84	0.33	0.42	0.54	0.7	0.67	0.6	-0.08	0.13	0.63		0.77	0.32	0.77	0.82	0.05	0.45	0.22	0.57	0.26	0.34	0.74	0.85	-0.12	0.75	0.8
Non Current Assets Total	0.98	-0.08	0.21	0.57	0.86	0.64	0.94	-0.42	0.31	0.65	0.77		0.57	0.71	0.91	-0.01	0.52	0.15	0.54	0.16	0.28	0.81	0.77	-0.22	0.93	0.93
Non Currrent Assets Other	0.46	-0.59	-0.45	-0.08	0.31	0.16	0.6	-0.76	0.84	0.23	0.32	0.57		0.29	0.27	-0.67	0.24	0.36	-0.29	-0.59	0.33	0.34	0.16	-0.51	0.47	0.42
Cash And Short Term Investments	0.81	0.15	0.23	0.39	0.84	0.43	0.61	-0.17	0.03	0.55	0.77	0.71	0.29		0.71	0.18	0.91	-0.12	0.55	0.38	-0.02	0.74	0.91	-0.21	0.67	0.73
Net Receivables	0.94	0.21	0.48	0.75	0.83	0.65	0.82	-0.14	0.05	0.7	0.82	0.91	0.27	0.71		0.24	0.49	0.09	0.73	0.39	0.27	0.75	0.87	0.04	0.87	0.94
Common Stock Shares Outstanding	0.09	0.44	0.47	0.37	0.32	0.18	-0.06	0.45	-0.9	0.22	0.05	-0.01	-0.67	0.18	0.24		0.21	-0.59	0.67	0.95	-0.48	0.06	0.28	0.38	0.11	0.19
Short Term Investments	0.62	0.01	0.02	0.22	0.73	0.18	0.49	-0.19	0.0	0.39	0.45	0.52	0.24	0.91	0.49	0.21		-0.27	0.38	0.36	-0.21	0.57	0.75	-0.2	0.44	0.52
Non Current Liabilities Total	0.1	0.14	-0.08	0.03	-0.34	0.3	0.24	0.05	0.52	0.21	0.22	0.15	0.36	-0.12	0.09	-0.59	-0.27		-0.16	-0.58	0.97	-0.01	-0.03	-0.25	0.1	0.13
Other Current Assets	0.62	0.51	0.65	0.67	0.63	0.61	0.49	0.3	-0.57	0.59	0.57	0.54	-0.29	0.55	0.73	0.67	0.38	-0.16		0.8	0.02	0.47	0.69	0.15	0.66	0.68
Other Stockholder Equity	0.28	0.54	0.57	0.49	0.49	0.36	0.06	0.46	-0.86	0.38	0.26	0.16	-0.59	0.38	0.39	0.95	0.36	-0.58	0.8		-0.44	0.26	0.49	0.37	0.24	0.34
Total Liab	0.25	0.23	0.13	0.28	-0.19	0.44	0.37	0.1	0.45	0.35	0.34	0.28	0.33	-0.02	0.27	-0.48	-0.21	0.97	0.02	-0.44		0.13	0.15	-0.09	0.24	0.29
Property Plant And Equipment Gross	0.86	0.18	0.42	0.57	0.81	0.66	0.66	-0.13	0.19	0.59	0.74	0.81	0.34	0.74	0.75	0.06	0.57	-0.01	0.47	0.26	0.13		0.83	-0.11	0.64	0.74
Total Current Assets	0.89	0.36	0.54	0.72	0.84	0.61	0.65	0.02	-0.05	0.67	0.85	0.77	0.16	0.91	0.87	0.28	0.75	-0.03	0.69	0.49	0.15	0.83		0.1	0.71	0.82
Short Term Debt	-0.13	0.37	0.62	0.6	-0.08	0.04	-0.25	0.44	-0.42	0.03	-0.12	-0.22	-0.51	-0.21	0.04	0.38	-0.2	-0.25	0.15	0.37	-0.09	-0.11	0.1		-0.19	-0.11
Intangible Assets	0.9	-0.1	0.29	0.59	0.81	0.58	0.92	-0.43	0.14	0.59	0.75	0.93	0.47	0.67	0.87	0.11	0.44	0.1	0.66	0.24	0.24	0.64	0.71	-0.19		0.91
Good Will	0.95	0.13	0.36	0.66	0.83	0.75	0.86	-0.21	0.08	0.82	0.8	0.93	0.42	0.73	0.94	0.19	0.52	0.13	0.68	0.34	0.29	0.74	0.82	-0.11	0.91

Click cells to compare fundamentals

Precigen Account Relationship Matchups

Precigen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	455.8M	314.6M	359.9M	216.0M	151.0M	143.5M
Short Long Term Debt Total	247.9M	182.3M	194.2M	51.4M	7.1M	6.7M
Other Current Liab	73.5M	31.7M	22.8M	30.1M	19.5M	29.9M
Total Current Liabilities	122.9M	42.1M	34.6M	78.6M	23.0M	21.8M
Total Stockholder Equity	71.7M	67.2M	107.3M	126.3M	118.5M	112.6M
Property Plant And Equipment Net	86.2M	44.3M	45.2M	15.4M	14.2M	13.5M
Current Deferred Revenue	5.7M	2.8M	4.4M	25K	509K	483.6K
Net Debt	182.2M	130.5M	151.3M	46.6M	(481K)	(457.0K)
Retained Earnings	(1.7B)	(1.8B)	(1.9B)	(1.9B)	(2.0B)	(1.9B)
Accounts Payable	5.9M	4.6M	5.4M	4.1M	1.7M	1.6M
Cash	65.8M	51.8M	42.9M	4.9M	7.6M	7.2M
Non Current Assets Total	221.1M	165.6M	203.2M	97.8M	82.3M	78.2M
Non Currrent Assets Other	(13.9M)	(8.6M)	(14.8M)	(8.5M)	(8.6M)	(8.2M)
Cash And Short Term Investments	75.1M	100.1M	115.2M	56.0M	62.9M	93.0M
Net Receivables	26.2M	20.4M	21.5M	13.8M	1.6M	1.5M
Common Stock Shares Outstanding	154.1M	167.1M	197.8M	200.4M	244.5M	134.9M
Short Term Investments	9.3M	48.3M	72.2M	51.1M	55.3M	53.0M
Liabilities And Stockholders Equity	455.8M	314.6M	359.9M	216.0M	151.0M	143.5M
Non Current Liabilities Total	261.1M	205.3M	217.9M	11.1M	18.7M	17.7M
Other Current Assets	6.4M	7.2M	6.7M	4.8M	4.3M	5.7M
Other Stockholder Equity	1.8B	1.9B	2.0B	2.0B	2.1B	1.4B
Total Liab	384.1M	247.4M	252.5M	89.7M	41.6M	39.6M
Total Current Assets	234.6M	148.9M	156.6M	118.2M	68.8M	65.3M
Accumulated Other Comprehensive Income	(27.5M)	4.0M	203K	(3.5M)	(3.9M)	(4.1M)
Short Term Debt	37.8M	3.0M	2.0M	44.4M	1.2M	1.1M
Intangible Assets	68.3M	65.4M	54.1M	44.5M	40.7M	78.7M
Good Will	63.8M	54.4M	54.1M	36.9M	26.6M	25.3M
Net Tangible Assets	(60.4M)	(52.6M)	(915K)	126.3M	113.6M	81.8M
Long Term Debt	211.2M	186.3M	171.5M	182.7M	210.2M	107.7M
Retained Earnings Total Equity	(1.7B)	(1.8B)	(1.9B)	(1.9B)	(1.7B)	(1.8B)
Long Term Debt Total	211.2M	186.3M	171.5M	182.7M	210.2M	107.7M
Capital Surpluse	1.8B	1.9B	2.0B	2.0B	2.3B	1.7B
Inventory	16.1M	11.4M	13.3M	287K	1.0	0.95
Deferred Long Term Liab	7.2M	2.8M	2.9M	2.5M	2.3M	2.2M
Non Current Liabilities Other	57.4M	72.0M	30.9M	32.6M	37.5M	27.7M
Property Plant Equipment	61.0M	34.9M	45.2M	7.3M	6.6M	6.3M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Precigen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Precigen's short interest history, or implied volatility extrapolated from Precigen options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Precigen using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:

How To Invest In Precigen

Details

Is Precigen Stock a good investment?

Details

What is Precigen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.

Note that the Precigen information on this page should be used as a complementary analysis to other Precigen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Precigen Stock analysis

When running Precigen's price analysis, check to measure Precigen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precigen is operating at the current time. Most of Precigen's value examination focuses on studying past and present price action to predict the probability of Precigen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precigen's price. Additionally, you may evaluate how the addition of Precigen to your portfolios can decrease your overall portfolio volatility.

	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Technical Analysis Check basic technical indicators and analysis based on most latest market data

Is Precigen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.39)

Revenue Per Share

0.025

Quarterly Revenue Growth

(0.30)

Return On Assets

(0.30)

Return On Equity

(0.78)

The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Precigen Long Term Debt vs Current Deferred Revenue Analysis

Long Term Debt vs Current Deferred Revenue

Long Term Debt vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Long Term Debt

Current Deferred Revenue

Precigen fundamental ratios Correlations

Precigen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Precigen fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Precigen Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 0.98	Total Assets
Total Liab	+ 0.97	Non Current Liabilities Total
Good Will	+ 0.95	Total Assets
Other Stockholder Equity	+ 0.95	Common Stock Shares Outstanding
Net Receivables	+ 0.94	Total Assets
Non Current Assets Total	+ 0.94	Current Deferred Revenue

Common Stock Shares Outstanding	- 0.9	Retained Earnings
Other Stockholder Equity	- 0.86	Retained Earnings
Non Currrent Assets Other	- 0.76	Net Debt
Common Stock Shares Outstanding	- 0.67	Non Currrent Assets Other
Retained Earnings	- 0.66	Net Debt
Non Current Liabilities Total	- 0.59	Common Stock Shares Outstanding